Oxysulfonyl urea ACAT inhibitors
    1.
    发明授权
    Oxysulfonyl urea ACAT inhibitors 失效
    氧基磺酰脲ACAT抑制剂

    公开(公告)号:US5364882A

    公开(公告)日:1994-11-15

    申请号:US984028

    申请日:1992-12-01

    CPC分类号: C07C307/02

    摘要: Compounds of the formula ##STR1## wherein R is hydrogen, a straight or branched alkyl group having from 1 to 8 carbon atoms or benzyl; wherein each of R.sub.1 and R.sub.2 is hydrogen, an aralkyl group, a straight or branched hydrocarbon group having from 1 to 20 carbon atoms and may be saturated or unsaturated, an alkyl group of from 1 to 6 carbon atoms wherein the terminal carbon is substituted, the group --(CH.sub.2).sub.p)--Q wherein p is zero to three and Q is a 5- or 6-membered monocyclic or fused bicyclic heterocycle, phenyl or NR.sub.1 R.sub.2 taken together form a monocyclic heterocyclic ring, and R.sub.3 is phenyl, substituted phenyl, naphthyl, substituted naphthyl, --(CH.sub.2).sub.p --Q wherein p and Q are as defined above, an aralkyl group or a straight or branched hydrocarbon group having from 1 to 20 carbon atoms and being straight or branched, which compounds are useful in treating hypercholesterolemia.

    摘要翻译: 其中R为氢,具有1至8个碳原子的直链或支链烷基或苄基的式IMAMA的化合物; 其中R 1和R 2各自为氢,芳烷基,具有1至20个碳原子并且可以是饱和或不饱和的直链或支链烃基,其中末端碳被取代的具有1至6个碳原子的烷基, 基团 - (CH 2)p)-Q其中p为0至3,Q为5或6元单环或稠合双环杂环,苯基或NR 1 R 2一起形成单环杂环,并且R 3为苯基,取代的苯基 ,萘基,取代的萘基, - (CH 2)pQ其中p和Q如上所定义,芳烷基或具有1至20个碳原子的直链或支链烃基是直链或支链的,该化合物可用于治疗高胆固醇血症 。

    Carbamate ACAT inhibitors
    7.
    发明授权
    Carbamate ACAT inhibitors 失效
    氨基甲酸酯ACAT抑制剂

    公开(公告)号:US5087726A

    公开(公告)日:1992-02-11

    申请号:US479313

    申请日:1990-02-13

    IPC分类号: C07C271/52

    CPC分类号: C07C271/52

    摘要: This invention relates to novel compounds which are ACAT inhibitors rendering them useful in lowering blood cholesterol levels. The compounds are carbamates represented by the general formula ##STR1## wherein Ar and Ar' represent phenyl or naphthyl each of which may be substituted; m and n each represent zero or one; Z and Y are hydrogen, aliphatic hydrocarbon, heterocyclic, aryl or carbocyclic containing groups.

    摘要翻译: 本发明涉及作为ACAT抑制剂的新型化合物,它们可用于降低血液中胆固醇水平。 这些化合物是由通式“IMAGE”表示的氨基甲酸酯,其中Ar和Ar'代表各自可被取代的苯基或萘基; m和n分别代表零或一; Z和Y是氢,脂族烃,杂环,芳基或含碳环基团。

    6-(2-(2-(Substituted amino)-3-quinolinyl) ethenyl and ethyl)
tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
    8.
    发明授权
    6-(2-(2-(Substituted amino)-3-quinolinyl) ethenyl and ethyl) tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis 失效
    6-(2-(2-(取代氨基)-3-喹啉基)乙烯基和乙基)四氢-4-羟基吡喃-2-酮胆固醇生物合成抑制剂

    公开(公告)号:US4923861A

    公开(公告)日:1990-05-08

    申请号:US307442

    申请日:1989-02-07

    IPC分类号: C07D215/38 C07D405/06

    CPC分类号: C07D215/38 C07D405/06

    摘要: Novel 6-[2-[2-(substituted amino)-3-quinolinyl]-ethenyl and ethyl]tetrahydro-4-hydroxypyran-2-ones and/or oxides and the corresponding dihydroxy ring opened acids and esters are described, as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) and are thus useful hypolipidemic and hypocholesterolemic agents.

    摘要翻译: 还描述了新的6- [2- [2-(取代的氨基)-3-喹啉基] - 乙烯基和乙基]四氢-4-羟基吡喃-2-酮和/或氧化物和相应的二羟基开环酸和酯 作为其制备方法和其药物组合物,其可用作3-羟基-3-甲基戊二酰辅酶A还原酶(HMG-CoA还原酶)的抑制剂,因此可用于降血脂和降血胆固醇剂。